Evidence map›Paper›PMID 34255681›Full record

ArticleJournal of medical Internet research2021

Application of an Anomaly Detection Model to Screen for Ocular Diseases Using Color Retinal Fundus Images: Design and Evaluation Study.

Yong Han, Weiming Li, Mengmeng Liu, Zhiyuan Wu, Feng Zhang, Xiangtong Liu, Lixin Tao, Xia Li, Xiuhua Guo

Open access · goldAbstract read
In one paragraph

Article in Journal of medical Internet research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Applications of generative adversarial networks in the diagnosis, prognosis, and treatment of ophthalmic diseases.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2025
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Yong HanDepartment of Epidemiology and Health Statistics, School of Public Health, Capital Medical University, Beijing, China.ORCID 0000-0001-8868-0327
Weiming LiDepartment of Epidemiology and Health Statistics, School of Public Health, Capital Medical University, Beijing, China.ORCID 0000-0002-7443-7067
Mengmeng LiuDepartment of Epidemiology and Health Statistics, School of Public Health, Capital Medical University, Beijing, China.ORCID 0000-0001-6357-2194
Zhiyuan WuDepartment of Epidemiology and Health Statistics, School of Public Health, Capital Medical University, Beijing, China.ORCID 0000-0001-5694-2441
Feng ZhangDepartment of Epidemiology and Health Statistics, School of Public Health, Capital Medical University, Beijing, China.ORCID 0000-0001-7442-1383
Xiangtong LiuDepartment of Epidemiology and Health Statistics, School of Public Health, Capital Medical University, Beijing, China.ORCID 0000-0001-8219-5064
Lixin TaoDepartment of Epidemiology and Health Statistics, School of Public Health, Capital Medical University, Beijing, China.ORCID 0000-0002-2135-046X
Xia LiDepartment of Mathematics and Statistics, La Trobe University, Melbourne, Australia.ORCID 0000-0003-1890-5548
Xiuhua GuoDepartment of Epidemiology and Health Statistics, School of Public Health, Capital Medical University, Beijing, China.ORCID 0000-0001-6657-6940
Capital Medical University · CNLa Trobe University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe supervised deep learning approach provides state-of-the-art performance in a variety of fundus image classification tasks, but it is not applicable for screening tasks with numerous or unknown disease types. The unsupervised anomaly detection (AD) approach, which needs only normal samples to develop a model, may be a workable and cost-saving method of screening for ocular diseases.

objectiveThis study aimed to develop and evaluate an AD model for detecting ocular diseases on the basis of color fundus images.

methodsA generative adversarial network-based AD method for detecting possible ocular diseases was developed and evaluated using 90,499 retinal fundus images derived from 4 large-scale real-world data sets. Four other independent external test sets were used for external testing and further analysis of the model's performance in detecting 6 common ocular diseases (diabetic retinopathy [DR], glaucoma, cataract, age-related macular degeneration, hypertensive retinopathy [HR], and myopia), DR of different severity levels, and 36 categories of abnormal fundus images. The area under the receiver operating characteristic curve (AUC), accuracy, sensitivity, and specificity of the model's performance were calculated and presented.

resultsOur model achieved an AUC of 0.896 with 82.69% sensitivity and 82.63% specificity in detecting abnormal fundus images in the internal test set, and it achieved an AUC of 0.900 with 83.25% sensitivity and 85.19% specificity in 1 external proprietary data set. In the detection of 6 common ocular diseases, the AUCs for DR, glaucoma, cataract, AMD, HR, and myopia were 0.891, 0.916, 0.912, 0.867, 0.895, and 0.961, respectively. Moreover, the AD model had an AUC of 0.868 for detecting any DR, 0.908 for detecting referable DR, and 0.926 for detecting vision-threatening DR.

conclusionsThe AD approach achieved high sensitivity and specificity in detecting ocular diseases on the basis of fundus images, which implies that this model might be an efficient and economical tool for optimizing current clinical pathways for ophthalmologists. Future studies are required to evaluate the practical applicability of the AD approach in ocular disease screening.

Indexed as

Diabetic RetinopathyArea Under CurveHumansMass ScreeningROC Curveanomaly detectionartificial intelligencecataractdiabetic retinopathydisease screeningeyefundus imageglaucomamacular degenerationocular diseaseophthalmology

Identifiers

PMID34255681
PMCPMC8317033
OpenAlexW3165337298

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.